Showing results (471-480 of 778) with videos related to
Sort By:
Pageof 78
Lancet (London, England)|February 28, 2017
Ethical issues in dialysis therapyVivekanand Jha, Dominique E Martin, Joanne M Bargman, et al.Scientific Reports|May 31, 2019
Engineering the vasculature of decellularized rat kidney scaffolds using human induced pluripotent stem cell-derived endothelial cellsOsele Ciampi, Barbara Bonandrini, Manuela Derosas, et al.Stem Cell Research|August 2, 2021
Human iPSC-derived neural crest stem cells can produce EPO and induce erythropoiesis in anemic miceValerio Brizi, Sara Buttò, Domenico Cerullo, et al.Biomedicines|December 24, 2021
Unravelling the Role of PAX2 Mutation in Human Focal Segmental GlomerulosclerosisLorena Longaretti, Piera Trionfini, Valerio Brizi, et al.The American Journal of Pathology|March 28, 2006
Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective interventionDaniela Macconi, Mauro Abbate, Marina Morigi, et al.Nature Reviews. Nephrology|December 7, 2018
Estimated GFR: time for a critical appraisalEsteban Porrini, Piero Ruggenenti, Sergio Luis-Lima, et al.International Journal of Molecular Sciences|November 25, 2023
Endothelial Glycocalyx of Peritubular Capillaries in Experimental Diabetic Nephropathy: A Target of ACE Inhibitor-Induced Kidney Microvascular ProtectionMonica Locatelli, Daniela Rottoli, Rayan Mahmoud, et al.JCI Insight|August 10, 2018
SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathyPaola Cassis, Monica Locatelli, Domenico Cerullo, et al.Scientific Reports|May 23, 2020
Manipulating Sirtuin 3 pathway ameliorates renal damage in experimental diabetesMonica Locatelli, Carlamaria Zoja, Cristina Zanchi, et al.Frontiers in Immunology|January 23, 2026
Acetylsalicylic acid disrupts SARS-CoV-2 spike protein glycosylation and selectively impairs binding to ACE2Luca Perico, Alessandra Bovio, Susanna Tomasoni, et al.Pageof 78